Thader TH Pharma has improved the method for obtaining the active ingredient, which guarantees a substantial improvement in the quality of the product and consequently in the capacity and activity of all the components that comprise it.
Thader TH Pharma continues to carry out its own research to continue working with previous results, and we can confirm that the products included in our TH-SCA formula help many people to significantly improve the condition of their skin.
Summary of the first impressions of the research currently being carried out:
“We analyse the complete hydrating treatment in patients diagnosed with oncological illness of the head or neck in radiotherapy.
In a recurring pattern, between the third and fourth week of treatment, patients present radiodermatitis that can develop to GII-III according to the dose of radiation given. This radiodermatitis can appear earlier if the radiation treatment is combined with chemotherapy or targeted therapy (Cetuximab).
In a study (ten patients) with application given twice a day, we observed:
– Radiodermatitis GI remained until the end of treatment, without becoming more serious.
– In one case in which moist dermatitis on the neck was combined with the application of a second moisturiser, when we went back to applying the study cream the dermatitis improved, even to a lower grade, and flaking disappeared.
– The development of most flaking is frequent in skin folds and by applying the cream the radiodermatitis does not reach this grade.